In Memoriam

In memoriam: Michael Sela

ASBMB Today Staff
May 22, 2023

Michael Sela, an immunologist and synthetic chemist who helped develop drugs to treat multiple sclerosis and cancer died May 27, 2022, in Rehovot, Israel. He was 98.

Michael Sela

A member of the American Society for Biochemistry and Molecular Biology since 1968, Sela was the sixth president of the Weizmann Institute of Science and founding director of its immunology department.

Sela was born Miechzslaw Salomoniwicz in Poland on Feb. 28, 1924. Rising antisemitism drove his family first to Romania, and then to Palestine, where Sela arrived at age 17. He earned a master’s degree in chemistry at the Hebrew University in 1946, then moved to Italy to help resettle Jewish refugees and served as a diplomat in Prague. In 1950, he went to the Weizmann Institute as a doctoral student of Efraim Katzir, later a president of Israel. He earned a Ph.D. in chemistry through Hebrew University.

Sela’s work on synthetic antigens helped illuminate how genes control the immune response. He was one of the first chemists to create multichain polymers of amino acids and polypeptide proteins. This basic science indirectly led to his co-inventing the drug Copaxone (glatiramer acetate) for multiple sclerosis and three cancer drugs cetuxibab, necitumumab and panitumumab.

In addition to serving as president of the Weizmann Institute from 1975 to 1985, Sela led the International Union of Immunological Societies, chaired the Council of the European Molecular Biology Organization and joined the Global Advisory Committee of the World Health Organization. He was a member of the Israel, U.S. National, Russian, French and Pontifical academies of sciences.

Among many honors, Sela received the 1980 Gairdner Foundation International Award, UNESCO's Albert Einstein Golden Medal in 1995 and the 1998 Wolf Prize in Medicine, shared with his first grad student, Ruth Arnon.

Sela enjoyed and supported the performing arts, from the Batsheva Dance Company to classical music, jazz, theater and opera. He was a gifted linguist, who mastered  Polish, Romanian, Hebrew, German, Russian, French, English, Italian and Czech.

Sela’s first wife, Margalit Liebman, died in 1975. He is survived by his wife, Sara Kika; daughters, Irit, Orlee and Tamar, and their spouses; grandchildren; and great-grandchildren.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Mapping proteins, one side chain at a time
Award

Mapping proteins, one side chain at a time

Jan. 7, 2026

Roland Dunbrack Jr. will receive the ASBMB DeLano Award for Computational Biosciences at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

2026 voter guide
Society News

2026 voter guide

Jan. 6, 2026

Learn about the candidates running for Treasurer-elect, Councilor and Nominating Committee.

Meet the editor-in-chief of ASBMB’s new journal, IBMB
Profile

Meet the editor-in-chief of ASBMB’s new journal, IBMB

Jan. 5, 2026

Benjamin Garcia will head ASBMB’s new journal, Insights in Biochemistry and Molecular Biology, which will launch in early 2026.

Exploring the link between lipids and longevity
Profile

Exploring the link between lipids and longevity

Jan. 2, 2026

Meng Wang will present her work on metabolism and aging at the ASBMB Annual Meeting, March 7-10, just outside of Washington, D.C.

Defining a ‘crucial gatekeeper’ of lipid metabolism
Award

Defining a ‘crucial gatekeeper’ of lipid metabolism

Dec. 31, 2025

George Carman receives the Herbert Tabor Research Award at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

Nuñez receives Vallee Scholar Award
Member News

Nuñez receives Vallee Scholar Award

Dec. 29, 2025

He will receive $400,000 to support his research.